Cicletanine
Grundinformationen
- CAS
89943-82-8- Standard-SMILES
Cc1ncc2c(c1O)COC2c1ccc(Cl)cc1- InChIKey
CVKNDPRBJVBDSS-UHFFFAOYSA-N- Summenformel
- C14H12ClNO2
- Durchschnittliche Molmasse
- 261,7 g/mol
- Monoisotopische Masse
- 261,0556563
Überblick
Cicletanine is an organochlorine compound.
Namen und Bezeichner
- Bevorzugter Name
- Cicletanine
- IUPAC
- 3-(4-chlorophenyl)-6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol
- Englischer Name
- Cicletanine
- Summenformel
- C14H12ClNO2
- Molmasse
- 261.7
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
89943-82-8- PubChem CID
- 54910
- DTXSID
DTXSID70868972- ChEMBL
CHEMBL191886- ChEBI
CHEBI:135078- UNII
- CHG7QC509W
- EC Number
- 630-329-0
- Nikkaji
- J55.610F
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,4
- Polarare Oberfläche (TPSA)
- 42,4 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 18
- Formalladung
- 0
- Komplexität
- 294
Experimentelle und physikochemische Eigenschaften
Physikochemische Eigenschaften
- Siedepunkt
- 446.3 · 446.3±45.0 °C(Predicted)
- Dichte
- 1.351 · 1.351±0.06 g/cm3(Predicted)
- pka
- 5.37 · 5.37±0.40(Predicted)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H318 (100%): Causes serious eye damage [Danger Serious eye damage/eye irritation]
P264+P265, P280, P305+P354+P338, and P317 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Gefahrenhinweise
Sicherheitsdaten
- Alarmwort
- Achtung
- Gefahrenhinweise
- Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H318
Chemie und Industrie
Pharmakologische Informationen
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Agents that promote the excretion of urine through their effects on kidney function.
Anwendungen
VerwendenAntihypertensive.
Anbieter6 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…